Return to The JAM Blog

Intrexon gets killed on earnings miss–adding the shares to my Volatility Portfolio

Back in my video "Biotech marijuana: What Took So Long?" on October 22, I said that I would buy shares of Intrexon (XON) if it closed above resistance. On yesterday's earnings miss, the shares plunged--forget about closing above resistance--by 18.38% to $10.79 as of 3 p.m. New York time on Friday, November 9. I don't […]

To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.